Insider Cluster (3 insiders) ·Filed Aug 31, 2026

MEDP

Medpace Holdings, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 3 insiders, $4.9M total
Actionable Insight • Neutral

This insider selling cluster is too small to warrant a directional trade. Monitor next quarterly earnings (likely late October) for any fundamental changes, but this filing alone provides no actionable signal.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
MEDP ▲ +4.73% at T+20d
NEUTRAL call ✓ call won +4.73% · α vs SPY +4.92% · entry $593.99 → $622.11
Next anchor: T+60d in 7w
Latest observation: T+21 -1.18% FF3 residual α
Entry anchored
Aug 28, 04:00 PM ET
via 1-min bar
T+1d
-1.81%
call -1.81% · α -1.13%
$583.21
settled 5w ago
T+5d
-0.52%
call -0.52% · α -0.38%
$590.89
settled 28d ago
T+20d
+4.73%
call +4.73% · α +4.92%
$622.11
settled 4d ago
T+60d
—
call — · α —
—
in 7w

Price Chart

Loading chart...

Executive Summary

Three Medpace insiders (CEO, CFO, Director) sold a combined $4.91M in open-market sales over a 7-day window. However, this represents only ~0.03% of the company's $16.8B market cap, making it a trivial, routine cluster unlikely to carry informational content. The sales are too small relative to company size to signal a bearish view, and the Director's sale was part of a derivative exercise-and-sell pattern, further reducing significance.

Key Financial Metrics

Direction
selling
Total Value
$4.9M
Insiders
3

Key Facts

  • Total open-market insider sales: $4.91M across 3 insiders (CEO, CFO, Director)
  • Sales represent only ~0.03% of MEDP's $16.8B market cap
  • CEO August Troendle sold 4,650 shares total (~$2.88M), CFO Kevin Brady sold 3,400 shares (~$2.13M)
  • Director Robert Kraft's $2.38M sale was part of a derivative exercise-and-sell pattern (non-cash exercise at $0)
  • No 10b5-1 plan or regular pattern noted, but absolute dollar amount is immaterial

Financial Impact

Insider sales of $4.91M are negligible relative to $16.8B market cap

dilution

Risk Factors

  • No material risk identified from this filing
  • Insider selling could increase if fundamentals deteriorate, but current cluster is trivial

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
35% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MEDP-1788246414471
15 reports for MEDP
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+20▲ +7.72%Dec 4, 2025
Filters
Rows
Reports for MEDP — sortable, filterable
TypeNow
Aug 31, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$593.99 $622.11▲ +4.73%▲ +4.92%$607.17 (+2.22%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 4/10
$600.65 $615.94▲ +2.55%▲ +2.29%$607.17 (+1.09%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$611.57 $620.59▲ +1.47%▲ +1.98%$607.17 (−0.72%)
Aug 25, 2026
5w ago
Insider Cluster
BEARISH ★ 5/10
$614.06 $617.15▼ −0.50%▲ +0.47%$607.17 (+1.12%)
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 4/10
$620.03 $630.19▲ +1.64%▲ +0.32%$607.17 (−2.07%)
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$620.75 $624.20▲ +0.56%▲ +1.08%$607.17 (−2.19%)
Aug 19, 2026
6w ago
144
NEUTRAL ★ 3/10
$608.27 $615.18▲ +1.14%▲ +3.09%$607.17 (−0.18%)
Aug 14, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$578.50 $595.41▲ +2.92%▲ +4.91%$607.17 (+4.96%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$581.95 $587.52▲ +0.96%▲ +2.70%$607.17 (+4.33%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$596.98 $583.16▼ −2.31%▼ −0.42%$607.17 (+1.71%)
Showing 10 of 15

US Market Status

Market Open — Closes in 3h 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 1, 2026